Skip to main content
OpenTrials
Completed

NCT Number: NCT04624165

Patient Perspective of Telemedicine in Gynecology Oncology

Research question: do patients in a gynecologic oncology practice value the use of telemedicine as an adjunct to in-person visits and in what circumstances might patients not find these visits to be sufficient?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Oncology Neoplasms

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

TriHealth - Good Samaritan and Bethesda North Hospitals

Cincinnati, Ohio, 45220, United States

About this study

In the United States, 14.8 million women live greater than 50 miles away from the closest gynecology oncologist underscoring the need for increased implementation of telemedicine. In consideration of the COVID-19 outbreak, recommendations were made to organize goals of therapy by prioritizing curative intent and utilizing telemedicine to manage current therapies. Research regarding telemedicine, its benefits, and patient perspectives in other specialties has been reported, however there appears to be a dearth of information in the field of gynecologic oncology. Our study aims to seek patients' perspective of telemedicine and whether implementation for extended office visits, teleconsultations and more are feasible and valuable to them.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

o Eligible patients would be at least 18 years of age, and currently being treated by one of the providers within the gynecologic oncology group.

Treatment and study plan

Survey

Other

o We plan to hand out copies of a survey to examine patient's perspective on telemedicine.

Primary outcomes

  1. Patient's perspective on telemedicine on a Likert Scale

    Time frame: Through survey completion, an average of 15 minutes

    Patient's perspective on telemedicine on a Likert Scale

Sponsors and collaborators

Lead sponsor

TriHealth Inc.

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Nov 10, 2020
Registry last updated
Aug 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.